Schedule-Dependent Synergistic Effect of Pemetrexed Combined with Gemcitabine against Malignant Pleural Mesothelioma and Non-Small Cell Lung Cancer Cell Lines

Publisher： Karger

E-ISSN： 1421-9794|54|3|166-175

ISSN： 0009-3157

Source： Chemotherapy, Vol.54, Iss.3, 2008-06, pp. : 166-175

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Intrapleural Administration of Cisplatin and Etoposide to Treat Malignant Pleural Effusions in Patients with Non-Small Cell Lung Cancer

By  

Chemotherapy, Vol. 45, Iss. 3, 1999-04 ,pp. : 197-204

Karger

Access to resources Recommend Favorite

Severe Immune Hemolytic Anemia due to Pemetrexed in a Patient with Non-Small Cell Lung Cancer

By  

Pharmacology, Vol. 88, Iss. 5-6, 2011-10 ,pp. : 242-244

Karger

Access to resources Recommend Favorite

Pemetrexed for Previously Treated Patients with Non-Small Cell Lung Cancer and Differences in Efficacy according to Thymidylate Synthase Expression

By  

Chemotherapy, Vol. 58, Iss. 4, 2012-11 ,pp. : 313-320

Karger

Access to resources Recommend Favorite

A Phase I Trial of Temsirolimus and Pemetrexed in Patients with Advanced Non-Small Cell Lung Cancer

By  

Chemotherapy, Vol. 61, Iss. 3, 2016-01 ,pp. : 144-147

Karger

Access to resources Recommend Favorite

Biweekly Vinorelbine and Gemcitabine as Second-Line Treatment and Beyond in Non-Small Cell Lung Cancer

By  

Chemotherapy, Vol. 56, Iss. 5, 2010-10 ,pp. : 353-358

Karger

Access to resources Recommend Favorite